Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-26 @ 2:41 PM
Ignite Modification Date:
2025-12-26 @ 2:41 PM
NCT ID:
NCT01920906
Eligibility Criteria:
Inclusion Criteria:
* Self-identified as Korean (defined as being Korean and both parents are Korean)
* History of small and/or large plaque psoriasis, for at least six months
* At least 18 years of age
* No treatment with topical steroids or vitamin D analogues for at least 2 weeks prior to entering the study.
* No treatment with systemic therapies, including phototherapy, acitretin, cyclosporine, methotrexate and biologics 4 weeks prior to entering the study. Among biologics, Ustekinumab (Stelara®) requires a longer washout period of 12 weeks.
Exclusion Criteria:
* Erythrodermic, or pustular psoriasis as the sole or predominant form of psoriasis.
* Photosensitizing illnesses such as lupus, polymorphous light eruption, or any disease known to be worsened by UV light exposure.
* History of malignant melanoma.
* Pregnancy.
* Immunocompromising diseases such as HIV infection.
* Inflammatory diseases such as but not limited to Crohn's Disease, Multiple Sclerosis, Rheumatoid Arthritis, Hashimoto's Disease.
* Any medical, psychological or social condition that, in the opinion of the Investigator, would jeopardize the health or well-being of the participant during any study procedures or the integrity of the data. Participants taking medications that induce photosensitivity may be included after careful review.
* Poorly controlled medical conditions of any kind.
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT01920906
Study Brief:
Protocol Section:
NCT01920906